Pirenzepine versus cimetidine in the treatment of duodenal ulcer. 1979

G Bianchi Porro, and M Petrillo, and M Lazzaroni, and P R Dal Monte, and N D'Imperio, and G Giuliani Piccari

Fifty-five patients with active duodenal ulcer have completed, up to today, a one-month double-blind trial to compare the effects of pirenzepine (150 mg daily), cimetidine (1 g daily) and placebo on the healing of duodenal ulcer. Fifteen (71%) of the 21 patients treated with pirenzepine had healed ulcers compared with 14 (82%) receiving cimetidine (P less than 0.05. In the placebo group there were 7 (41%) healed ulcers. Symptomatic improvement in patients given pirenzepine was as substantial as in cimetidine-treated patients. No adverse effects were noted.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D010890 Pirenzepine An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients. Gastrotsepin,Gastrozepin,L-S 519,LS-519,Piren-Basan,Pirenzepin,Pirenzepin Von Ct,Pirenzepin-Ratiopharm,Pirenzepine Dihydrochloride,Pyrenzepine,Ulcoprotect,Ulgescum,Dihydrochloride, Pirenzepine,LS 519,LS519,Piren Basan,Pirenzepin Ratiopharm,Von Ct, Pirenzepin
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002927 Cimetidine A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output. Altramet,Biomet,Biomet400,Cimetidine HCl,Cimetidine Hydrochloride,Eureceptor,Histodil,N-Cyano-N'-methyl-N''-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)guanidine,SK&F-92334,SKF-92334,Tagamet,HCl, Cimetidine,Hydrochloride, Cimetidine,SK&F 92334,SK&F92334,SKF 92334,SKF92334
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004381 Duodenal Ulcer A PEPTIC ULCER located in the DUODENUM. Curling's Ulcer,Curling Ulcer,Curlings Ulcer,Duodenal Ulcers,Ulcer, Curling,Ulcer, Duodenal,Ulcers, Duodenal

Related Publications

G Bianchi Porro, and M Petrillo, and M Lazzaroni, and P R Dal Monte, and N D'Imperio, and G Giuliani Piccari
January 1988, Deutsche Zeitschrift fur Verdauungs- und Stoffwechselkrankheiten,
G Bianchi Porro, and M Petrillo, and M Lazzaroni, and P R Dal Monte, and N D'Imperio, and G Giuliani Piccari
February 1984, Gut,
G Bianchi Porro, and M Petrillo, and M Lazzaroni, and P R Dal Monte, and N D'Imperio, and G Giuliani Piccari
March 1985, Scandinavian journal of gastroenterology,
G Bianchi Porro, and M Petrillo, and M Lazzaroni, and P R Dal Monte, and N D'Imperio, and G Giuliani Piccari
January 1982, Scandinavian journal of gastroenterology. Supplement,
G Bianchi Porro, and M Petrillo, and M Lazzaroni, and P R Dal Monte, and N D'Imperio, and G Giuliani Piccari
November 1987, The American journal of gastroenterology,
G Bianchi Porro, and M Petrillo, and M Lazzaroni, and P R Dal Monte, and N D'Imperio, and G Giuliani Piccari
August 1988, The American journal of gastroenterology,
G Bianchi Porro, and M Petrillo, and M Lazzaroni, and P R Dal Monte, and N D'Imperio, and G Giuliani Piccari
July 1982, La Clinica terapeutica,
G Bianchi Porro, and M Petrillo, and M Lazzaroni, and P R Dal Monte, and N D'Imperio, and G Giuliani Piccari
January 1979, Scandinavian journal of gastroenterology. Supplement,
G Bianchi Porro, and M Petrillo, and M Lazzaroni, and P R Dal Monte, and N D'Imperio, and G Giuliani Piccari
January 1982, Scandinavian journal of gastroenterology. Supplement,
G Bianchi Porro, and M Petrillo, and M Lazzaroni, and P R Dal Monte, and N D'Imperio, and G Giuliani Piccari
January 1982, Scandinavian journal of gastroenterology. Supplement,
Copied contents to your clipboard!